Cue Biopharma Other Long Term Liabilities (Quarterly) Analysis

Cue Biopharma, Inc. (CUE)

0.3506 +0.01 (+1.62%) USD | NASDAQ | Jan 13, 16:00

0.3531 0.00 (0.00%) After-Hours: 20:00

View Other Long Term Liabilities (Quarterly) for CUE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	Upgrade
Puma Biotechnology, Inc.	Upgrade
Mersana Therapeutics, Inc.	--
Adaptive Biotechnologies Corp.	Upgrade
NovaBay Pharmaceuticals, Inc.	--